LETTER
Megestrol for AIDS-Related Anorexia
David C. Hodgson and
Donald A. Redelmeier
1 June 1995 | Volume 122 Issue 11 | Pages 879-881
TO THE EDITOR:
Von Roenn and colleagues' provocative study [1] examined the effects of megestrol acetate in patients with the acquired immunodeficiency syndrome (AIDS). Perhaps the most important clinical observation was that increased body weight correlated strongly with improved patient perceptions of well-being. The most striking research finding, however, was not discussed, namely, that the distribution of weight gains was identical to the distribution of psychological gains. Although we would like to believe that this finding is due to the harmonious marriage of mind and body among study patients, we suspect it may simply represent a layout error.
1. Von Roenn JH, Armstrong D, Kotler DP, Cohn DL, Klimas NG, Teheckmedyian NS, et al. Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med. 1994; 121:393-9.[Abstract/Free Full Text]
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Top
REFERENCE
Article
